Enzalutamide is under clinical development by Pfizer and currently in Phase II f...
(Curcumin + doxorubicin) is under clinical development by Immix BioPharma and cu...
Mecbotamab vedotin is under clinical development by BioAtla and currently in Pha...
(Curcumin + doxorubicin) is under clinical development by Immix BioPharma and cu...
Lenvatinib mesylate is under clinical development by Eisai and currently in Phas...
“The author owes the FDA an apology”: STAT readers on patient advocacy, the util...
“We do have secondary primary malignancy discussions with patients in the contex...
Drug companies say Medicare drug price negotiation will discourage drug research...
Understand how science, health policy, and medicine shape the world everyday. Si...
Want to stay on top of the science and politics driving biotech today? Sign up t...
Bristol Myers agreed to pay $14 billion for Karuna Therapeutics, which has an ex...
Bristol Myers Squibb said Friday that it will acquire Karuna Therapeutics, a dev...
“Every Christmas since my daughter died, I have tried to run away from those mem...
“Family medicine and primary care's obituary has been written many times in my 2...
In the world of infectious diseases and global health, if it’s not one thing, it...
The drug is a monthly injection for a genetic disorder called ATTR-PN, which aff...
